Black Friday saleUp to 70% OFF
444

GENOVATE BIOTECHNOLOGY CO. LTD.

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

4130 chart


Full chart

4130 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.42 B‬ TWD
Dividend yield (indicated)
0.67%
Price to earnings Ratio (TTM)
155.65
Basic EPS (TTM)
0.15 TWD
Net income (FY)
‪29.33 M‬ TWD
Revenue (FY)
‪528.51 M‬ TWD
Shares float
‪69.41 M‬
Beta (1Y)
0.23

About GENOVATE BIOTECHNOLOGY CO. LTD.


Sector
Health Technology
CEO
Chia Chen Chu
Headquarters
Hsinchu
Website
genovate-bio.com
Founded
1993
ISIN
TW0004130000
FIGI
BBG000BCFZ06
Genovate Biotechnology Co., Ltd. engages in the research, development, manufacture, and sale of specialty pharmaceutical products. Its product includes antimicrobial agents, anticancer agents, cardiovascular system drugs, alimentary tract and metabolic drugs, dermatologic agents, musculoskeletal drugs, nervous system drugs, respiratory drugs, and urinary system drugs. The company was founded on March 24, 1993 and is headquartered in Hsinchu, Taiwan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4130 is 21.75 TWD — it has decreased by −0.46% in the past 24 hours. Watch GENOVATE BIOTECHNOLOGY CO. LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange GENOVATE BIOTECHNOLOGY CO. LTD. stocks are traded under the ticker 4130.
4130 stock has fallen by −0.91% compared to the previous week, the month change is a −3.12% fall, over the last year GENOVATE BIOTECHNOLOGY CO. LTD. has showed a −19.99% decrease.
4130 reached its all-time high on Jul 18, 2014 with the price of 70.75 TWD, and its all-time low was 4.80 TWD and was reached on Jun 30, 2005. View more price dynamics on 4130 chart.
See other stocks reaching their highest and lowest prices.
4130 stock is 0.92% volatile and has beta coefficient of 0.23. Track GENOVATE BIOTECHNOLOGY CO. LTD. stock price on the chart and check out the list of the most volatile stocks — is GENOVATE BIOTECHNOLOGY CO. LTD. there?
Today GENOVATE BIOTECHNOLOGY CO. LTD. has the market capitalization of ‪2.44 B‬, it has increased by 0.23% over the last week.
Yes, you can track GENOVATE BIOTECHNOLOGY CO. LTD. financials in yearly and quarterly reports right on TradingView.
GENOVATE BIOTECHNOLOGY CO. LTD. is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
4130 net income for the last quarter is ‪5.56 M‬ TWD, while the quarter before that showed ‪7.99 M‬ TWD of net income which accounts for −30.46% change. Track more GENOVATE BIOTECHNOLOGY CO. LTD. financial stats to get the full picture.
Yes, 4130 dividends are paid annually. The last dividend per share was 0.15 TWD. As of today, Dividend Yield (TTM)% is 0.67%. Tracking GENOVATE BIOTECHNOLOGY CO. LTD. dividends might help you take more informed decisions.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOVATE BIOTECHNOLOGY CO. LTD. EBITDA is ‪52.66 M‬ TWD, and current EBITDA margin is 12.03%. See more stats in GENOVATE BIOTECHNOLOGY CO. LTD. financial statements.
Like other stocks, 4130 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOVATE BIOTECHNOLOGY CO. LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOVATE BIOTECHNOLOGY CO. LTD. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOVATE BIOTECHNOLOGY CO. LTD. stock shows the sell signal. See more of GENOVATE BIOTECHNOLOGY CO. LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.